Related Experiment Video
Updated: Jul 14, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Protection from acute and chronic lung diseases by curcumin
Narayanan Venkatesan1, Durairaj Punithavathi, Mary Babu
1Faculte de Medecine, UMR-7561, CNRS UHP, Vandoeuvre lès Nancy, France. vnar12@yahoo.com
Advances in Experimental Medicine and Biology
|June 16, 2007
Summary
Curcumin, a compound from turmeric, shows promise in treating lung injuries. Research indicates its potential to reduce inflammation and oxidative stress in various lung diseases.
Area of Science:
- * Pharmacology and Toxicology
- * Natural Product Chemistry
- * Respiratory Medicine
Background:
- * Lung injuries result from occupational, environmental, and medical exposures, leading to acute and chronic inflammatory diseases.
- * Current treatments for lung diseases offer limited benefits, highlighting the need for novel therapeutic agents.
- * Curcumin, a phytochemical from turmeric (Curcuma longa), exhibits diverse therapeutic properties and protective effects.
Purpose of the Study:
- * To review the therapeutic potential of curcumin for acute and chronic lung injuries.
- * To summarize evidence from experimental models regarding curcumin's efficacy in lung disease.
- * To explore curcumin's role in preventing or modulating inflammation and oxidative stress in lung conditions.
Main Methods:
- * Comprehensive literature review of preclinical studies on curcumin and lung injury.
- * Analysis of experimental animal models investigating curcumin's effects on lung fibrosis, inflammation, and oxidative stress.
- * Examination of pharmacological data supporting curcumin's protective mechanisms.
Main Results:
- * Curcumin demonstrated efficacy in attenuating lung injury and fibrosis in animal models induced by radiation, chemotherapy, and toxicants.
- * Studies suggest curcumin plays a protective role in conditions such as chronic obstructive pulmonary disease, acute lung injury, acute respiratory distress syndrome, and allergic asthma.
- * Curcumin's therapeutic action is linked to the prevention or modulation of inflammation and oxidative stress.
Conclusions:
- * Preclinical evidence strongly supports curcumin's therapeutic potential for a range of lung injuries and diseases.
- * Curcumin's anti-inflammatory and antioxidant properties make it a promising candidate for novel lung disease therapies.
- * Further clinical investigation of curcumin in patients with lung diseases is warranted.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.